CLINICAL PHARMACOLOGY (CP) VS. PHARMACEUTICAL MEDICINE (PM) EXPERIENCE FROM SERBIA

被引：0
|
作者：
Stanimirovic, V [1 ]
Djakovic-Svajcer, K. [2 ]
Solarevic, T. [1 ]
Mikov, M. [2 ]
Cebedzic, R. [1 ]
Stanimirovic, B. [1 ]
机构：
[1] Agcy Med & Med Devices Serbia Belgrade ALIMS, Belgrade, Serbia
[2] Univ Novi Sad, Dept Pharmacol Toxicol & Clin Pharmacol, Novi Sad 21000, Serbia
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2009年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [21] From Molecule to Patient: Building Bridges Not Walls with Clinical Pharmacology and Translational Medicine
    Uemura, Naoto
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (02): : 84 - 84
  • [22] Comparison of the Rate of Heart Transplant Rejection in Clinical Trials vs. Registries vs. Single Center: Which is More Reliable for Real World Experience?
    Ng, M.
    Singer-Englar, T.
    Kanungo, A.
    Bhatnagar, N.
    Hamilton, M.
    Kobashigawa, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01) : 25 - 25
  • [23] A Comparative Clinical Pharmacology Analysis of FDA-Approved Targeted Covalent Inhibitors vs. Reversible Inhibitors in Oncology
    Ngo, Huy X.
    Wen, Yue Winnie
    Pisupati, Swathi
    Huang, Weize
    Mandlekar, Sandhya
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (05) : 1198 - 1206
  • [24] The clinical pharmacology of thioguanine vs. mercaptopurine in ALL97, a randomized trial for the treatment of childhood lymphoblastic leukaemia
    Lennard, Lynne
    Cartwright, Cher
    Wade, Rachel
    Richards, Sue
    Mitchell, Chris
    Kinsey, Sally
    Eden, O. B.
    Vora, Ajay
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (06) : 994 - 994
  • [25] Transported vs. local contributions from secondary and biomass burning sources to PM2.5
    Kim, Bong Mann
    Seo, Jihoon
    Kim, Jin Young
    Lee, Ji Yi
    Kim, Yumi
    ATMOSPHERIC ENVIRONMENT, 2016, 144 : 24 - 36
  • [26] Diesel vs. gasoline emissions: Does PM from diesel or gasoline vehicles dominate in the US?
    Gertler, AW
    ATMOSPHERIC ENVIRONMENT, 2005, 39 (13) : 2349 - 2355
  • [27] Functional Precision Medicine Vs Genomics Vs Clinical Experience: Feasibility Results from the Multicentric, Prospective, Randomized Controlled Exalt-2 Trial
    Kazianka, Lukas
    Pemovska, Tea
    Rohrbeck, Johannes
    Kornauth, Christoph
    Pichler, Alexander
    Agreiter, Christiane
    Lubowitzki, Simone
    Prochazka, Katharina
    Neumeister, Peter
    Schmitt, Clemens
    Greil, Richard
    Willenbacher, Wolfgang
    Wolf, Dominik
    Jaeger, Ulrich
    Simonitsch-Klupp, Ingrid
    Staber, Philipp Bernhard
    BLOOD, 2023, 142
  • [28] Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience
    Cohn-Cedermark, G.
    Stahl, O.
    Tandstad, T.
    ANDROLOGY, 2015, 3 (01) : 102 - 110
  • [29] Long-Term Clinical Outcome of Cardiogenic Shock Patients Undergoing Impella CP Treatment vs. Standard of Care
    Scherer, Clemens
    Luesebrink, Enzo
    Kupka, Danny
    Stocker, Thomas J.
    Stark, Konstantin
    Stremmel, Christopher
    Orban, Mathias
    Petzold, Tobias
    Germayer, Antonia
    Mauthe, Katharina
    Kaab, Stefan
    Mehilli, Julinda
    Braun, Daniel
    Theiss, Hans
    Brunner, Stefan
    Hausleiter, Joerg
    Massberg, Steffen
    Orban, Martin
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 14
  • [30] Common sources of disparate results and experience in clinical practice vs. results from phase 2 registration studies: lamotrigine as a prototype
    Bowden, C. L.
    ACTA PSYCHIATRICA SCANDINAVICA, 2015, 132 (05) : 355 - 356
12345